Bio-Rad Introduces Chromogenic Medium in the U.S. for Rapid Screening of MRSA
Bio-Rad Laboratories, Inc. have introduced its MRSASelectTM test to the U.S. market, MRSASelectis a chromogenic medium used for the rapid screening of MRSA. Bio-Rad received FDA clearance for marketing its MRSASelect test in the U.S. in September. With high sensitivity and specificity as well as rapid and direct identification, the MRSASelect test can identify MRSA carriers in 24 hours. The MRSASelect test was introduced in Canada in 2005 and today it is the market leader there.
Source: Bio-Rad Laboratories View latest company information
Posted: November 6, 2007
[will open your email client]